Top 50 Health Care Startup Investors in Finland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
18 | Finland, United States, United Kingdom | Grant, Seed, Debt Financing | Software, Biotechnology, SaaS | $53k–$11M |
|
Butterfly Ventures
VC Fund
|
17 | Finland, Sweden, Norway | Seed, Pre-Seed | Health Care, Software, Information Technology | $110k–$4.4M |
|
Lifeline Ventures
VC Fund
|
16 | Finland, United States, United Kingdom | Seed, Series A | Software, Health Care, E-Commerce | $547k–$20M |
|
Finnvera Venture Capital
VC Fund
|
15 | Finland, United States, Chile | Seed, Series A | Software, Health Care, Information Technology | $250k–$22M |
|
Voima Ventures
VC Fund
|
13 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $439k–$18M |
|
Tesi
VC Fund
|
13 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Health Care | $2.2M–$41M |
|
Icebreaker.vc
VC Fund
|
12 | Finland, Estonia, Sweden | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $106k–$25M |
|
Innovestor
VC Fund
|
10 | Finland, Denmark, Sweden | Seed, Pre-Seed | Software, Health Care, Information Technology | $163k–$4.5M |
|
Ali Omar
Angel
|
8 | Finland, United States, Estonia | Seed, Pre-Seed, Angel | Software, SaaS, Artificial Intelligence | $53k–$2.1M |
|
Springvest
VC Fund
|
7 | Finland | Series A, Seed | Biotechnology, Health Care, Energy | $1.5M–$53M |
|
Redstone.VC
VC Fund
|
7 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Health Care | $505k–$17M |
|
Inventure
VC Fund
|
5 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$23M |
|
Leena Niemistö
Angel
|
5 | Finland, United States | Seed, Pre-Seed | Health Care, Software, E-Commerce | $480k–$3.2M |
|
Reaktor Ventures
VC Fund
|
5 | Finland, Germany, United States | Seed, Pre-Seed, Series A | Internet, Software, E-Commerce | $137k–$6.6M |
|
Nordic Science Investments
VC Fund
|
5 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Visionplus
VC Fund
|
5 | Finland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Internet | $77k–$14M |
|
Oy Hammaren & Co Ab
VC Fund
|
4 | Finland | Angel, Series A | Health Care, Wellness, GreenTech | |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $900k–$37M |
|
Nidoco
VC Fund
|
4 | Finland, Sweden, Estonia | Seed, Series A | Software, Health Care, Apps | $327k–$2.7M |
|
Superhero Capital
VC Fund
|
4 | Finland, Lithuania, Estonia | Seed, Pre-Seed | Software, Information Technology, Internet | $212k–$3.1M |
|
VTT Ventures
VC Fund
|
4 | Finland | Seed, Series A | Biotechnology, Manufacturing, Sensor | $460k–$13M |
|
Jyri Engestrom
Angel
|
3 | United States, Finland, Spain | Seed, Pre-Seed, Series A | Software, Apps, Internet | $600k–$20M |
|
Almaral
VC Fund
|
3 | Finland | Seed | Medical Device, Software, Education | $1.1M–$2.9M |
|
Johannes Schildt
Angel
|
3 | Sweden, Finland, United States | Seed, Pre-Seed, Series A | Health Care, Software, Information Technology | $641k–$18M |
|
Lynx Capital
VC Fund
|
3 | Finland | Series A, Seed | Health Care, Medical, Therapeutics | |
|
University of Helsinki
VC Fund
|
3 | Finland, Luxembourg, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Diagnostics, Apps | $837k–$7.4M |
|
Nostetta Ventures
VC Fund
|
3 | Finland | Seed, Pre-Seed | Health Care, Medical Device | $1.1M–$2.9M |
|
Antler
VC Fund
|
3 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $104k–$29M |
|
M Ventures
VC Fund
|
3 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | |
|
Cor Group
VC Fund
|
3 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $2.4M–$8.7M |
|
Sitra
VC Fund
|
3 | Finland, The Netherlands | Series A, Series C | Health Care, Biotechnology, Therapeutics | |
|
Stefan Lindberg
Angel
|
3 | Finland | Seed, Pre-Seed | Wellness, Nutrition, Fruit | $173k–$549k |
|
Athensmed
VC Fund
|
3 | Finland | Seed, Series A | Health Care, Medical, mHealth | $1.1M–$1.3M |
|
Elias Aalto
Angel
|
3 | Finland, Sweden, Estonia | Seed, Pre-Seed, Series A | Internet, Health Care, Information Technology | $430k–$10M |
|
European Investment Bank
VC Fund
|
2 | Germany, France, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | |
|
Heraeus
VC Fund
|
2 | Germany, China, Japan | Seed, Corporate Round, Series A | Manufacturing, Biotechnology, Therapeutics | $4.4M–$8.5M |
|
Vesalius Biocapital Partners
VC Fund
|
2 | Belgium, Germany, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Mika Ihamuotila
Angel
|
2 | Finland | Seed, Post-IPO Equity | Sustainability, FinTech, Internet | |
|
Stephen Industries
VC Fund
|
2 | Finland | Seed, Series A | Apps, Water, Energy | |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
Pontos Group
VC Fund
|
2 | Finland | Genetics, Hospital, Automotive | ||
|
Kustaa Piha
Angel
|
2 | Finland | Seed | Health Care, Health Diagnostics, Medical Device | $549k–$1.3M |
|
Conor Venture Partners
VC Fund
|
2 | Finland, United States, Sweden | Series A, Series B, Seed | Software, Analytics, Semiconductor | $1.1M–$16M |
|
Samsung Venture Investment
VC Fund
|
2 | South Korea, United States, India | Series A, Series B, Seed | Information Technology, Software, Health Care | |
|
Korpun Siemen
VC Fund
|
2 | Finland | Seed, Angel | Software, Information Technology, Pet | |
|
Asko Schrey
Angel
|
2 | Finland | Seed, Angel | Software, Artificial Intelligence, FinTech | |
|
Kristian Ranta
Angel
|
2 | Finland, United States | Seed, Pre-Seed | Health Care, Apps, Internet | $137k–$3.5M |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $573k–$22M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
| Access all 326 investors in Finland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Seed, Debt Financing
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 197
- Round size: Seed $297k–$3.5M; Grant $53k–$11M; Debt Financing $241k–$5.8M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Agileday — Connect your business elements in one tool and manage your entire operations with Agileday. Match sales, projects, and talent together and optimize your business.
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Valio — We are Valio Group: the most innovative dairy and food company in the world.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 87
- Round size: Seed $219k–$2.1M; Pre-Seed $110k–$4.4M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Atium — Clean water is one of the largest future challenges we stand before, and toxic pollutants are a large contributing factor. Heavy metals are some of the most toxic chemicals to human health and it is our goal, through our innovation, to contribute to a world where water treatment is more environmentally friendly and effective. Atium exists to helpensure clean water, for everyone.
- Reactional Music — Reactional Music is creating a new commercial layer for the global games industry that uses premium, licensed music to drive both user acquisition and player engagement. The company’s technology allows developers and publishers to integrate commercial music at two critical points in the player lifecycle:- Music in User Acquisition – improvingconversion, ROI, and campaign lifespan in playable ads and performance marketing.- Music in Games – increasing retention, session length, and monetization through adaptive, personalized music experiences.Reactional’s platform combines a patented rule-based adaptive music engine, a licensed catalog of more than six million tracks, and an automated rights and royalty system. The technology is already integrated with Unity and Unreal and is deployed across live projects with leading publishers and studios.
- Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 179
- Round size: Seed $547k–$5.4M; Series A $2.7M–$20M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $171M in 2023
Portfolio highlights
- Realm — Realm is a search engine for the workplace reimagined with AI. Designed to help fast-moving teams better leverage their collective knowledge.
- Thor Dynamics — Headquartered in Orlando, Florida, with a European base in Finland, Thor Dynamics specializes in directed energy systems for defense against drones and drone swarms. The company’s innovative solutions are available worldwide to protect critical infrastructure and enhance national security. Laser Armor™ is a complete directed energy counter-dronesolution. Utilizing advanced radar and optical systems it can detect, track, and target hostile targets. High-power directed energy from Thor’s Laser Engines then eliminates the threat in seconds. Multiple safety systems ensure accurate target identification and minimal collateral damage.
- Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Finland, United States, Chile
Investor stats
- Total investments: 94
- Round size: Seed $250k–$2.3M; Series A $1.7M–$22M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
- CHAOS — CHAOS is an urban forecasting company for real estate investors and city developers. Our AI platform processes urban data and crowd insights to forecast investment and development for creating liveable cities.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.9M; Pre-Seed $439k–$2.1M; Series A $3.8M–$18M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
- Sofi Filtration — Innovation in Industrial Liquid Filtration
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 142
- Round size: Series A $2.2M–$41M; Series B $3.1M–$35M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.
- Kide Science — Kide Science supports young children's scientific thinking through play-based learning, which predicts better learning outcomes in school.
- MaaS Global — Whim combines all the transportation you need: Public transport, shared cars, bikes, e-scooters, taxis, and more! One app to plan, book, and pay.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Estonia, Sweden
Investor stats
- Total investments: 122
- Round size: Seed $384k–$5.2M; Pre-Seed $106k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $22M in 2021
Portfolio highlights
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 79
- Round size: Seed $507k–$4.5M; Pre-Seed $163k–$2M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Innomost — Innomost develops and produces high-value bioactive ingredients from forest industry side streams that enable customers to make innovations in the cosmetic beauty industry. Its current product portfolio consists of birch charcoal powder, birch bark powder, betulin, suberin, and azelaic acid, which can trigger innovation in all cosmetic productcategories including skincare, haircare, body care, decorative cosmetics, and oral care.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Finland, United States, Estonia
Investor stats
- Total investments: 62
- Round size: Seed $263k–$2.1M; Angel $53k–$1.6M; Pre-Seed $163k–$724k
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
- React & Share — High volume, high quality feedback directly from your customers. React & Share helps digital comms teams improve their websites and satisfy their customers.
- Plain Complex — VUOROX IS AN AI-POWERED ROSTER SCHEDULING APP FOR HEALTHCARE
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 23
- Round size: Seed $1.5M–$7.6M; Series A $3.6M–$53M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 167
- Round size: Seed $505k–$6.6M; Pre-Seed $1.3M–$3.1M; Series A $1.6M–$17M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $57M in 2023
Portfolio highlights
- UpHill — Clinical algorithms, medical events, scientific evidence and a simulation software in one place
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 165
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
- Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
Leena Niemistö
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 18
- Round size: Seed $480k–$3.2M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
- Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 54
- Round size: Seed $137k–$2M; Pre-Seed $159k–$1.8M; Series A $1.7M–$6.6M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
- Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 16
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.8M
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $77k–$1.3M; Series A $2M–$14M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Film Finances — Discover Film Finances Inc., the global leader in film completion guarantees, ensuring on-schedule and on-budget delivery for over seven decades. Explore our services and industry expertise.
- LiveMusicStage — We're a live music venue online. We let you to actually take part in the shows and interact with the bands while they're playing. You're always in the front row
- Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more...Investment focus
- Industry: Health Care, Wellness, GreenTech
- Stage:Angel, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Heltti — We are Heltti! We help people and knowledge workplaces feel better.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 93
- Round size: Seed $900k–$8M; Pre-Seed $1.1M–$2.7M; Series A $3.3M–$37M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Yaak Technologies ApS — Safety in urban self-driving is currently an afterthought. At Yaak, we distill safety from driving experts for the next generation of human and autonomous driving.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more...Investment focus
- Industry: Software, Health Care, Apps
- Stage:Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 24
- Round size: Seed $327k–$2.7M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
- TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
- CHAOS — CHAOS is an urban forecasting company for real estate investors and city developers. Our AI platform processes urban data and crowd insights to forecast investment and development for creating liveable cities.
Some call you founders. We call you Superheroes. Seed stage VC investing in insight-driven startups in Finland and the Baltics. Tickets 100 K€ - 1000 K€.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Pre-Seed
- Geography: Finland, Lithuania, Estonia
Investor stats
- Total investments: 93
- Round size: Seed $212k–$3.1M; Pre-Seed $618k–$1.8M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Zadaa — We are the world’s first marketplace to make selling and buying secondhand as simple as in an online store. We have revolutionised C2C logistics regarding pricing and marketplace integration between multiple logistic companies operating on different markets. Zadaa is live on German, Danish and Finnish markets.
- eMabler — We accelerate our customers' business growth by convenience in eMobility with our API-first platform
- ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Sensor
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 24
- Round size: Seed $460k–$6M; Series A $1.7M–$13M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more...Investment focus
- Industry: Software, Apps, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Finland, Spain
Investor stats
- Total investments: 30
- Round size: Seed $600k–$4.7M; Series A $2.8M–$20M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
- Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
- Gyroscope Innovations — Gyroscope Innovations is a new OS for the human body. It was started by Anand Sharma in 2014 as a personal project called April Zero.
Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.
Show more...Investment focus
- Industry: Medical Device, Software, Education
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Seppo — Seppo is an online programme for creating educational games. It can be used on all levels from pre-school to university.
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Johannes Schildt, a true serial entrepreneur who founded or co-founded more than 3 companies, started his first company while still in school. Schildt later made a meteoric career at Stardoll working alongside people like Henrik Torstensson & Marcus Gners. Johannes successfully launched Stardoll's first official Facebook game, reaching1,000,000 monthly unique users within 3 months after launch. Today, Johannes is the CEO & Co-founder of Kry. By combining new technology with leading medical expertise KRY has built a platform to make healthcare digital.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, Finland, United States
Investor stats
- Total investments: 13
- Round size: Seed $2.8M–$4.4M; Pre-Seed $641k–$3.2M; Series A $17M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
- Cerrion — Cerrion is a visual AI that helps production teams react faster to process deviations, automate root cause analysis, and implement targeted improvement actions. They believe that process transparency enabled by AI and computer vision is key to achieving more autonomy and sustainability in manufacturing. Their software is built and designed withproduction teams from all over the world in the loop.
- Veri — Reveal the foods that help you feel and perform at your best. Track your metabolic health to manage weight, reduce stress and improve sleep.
cross-border, healthcare, life science, investment, VC, China, US
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
- Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
Show more...Investment focus
- Industry: Biotechnology, Health Diagnostics, Apps
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Luxembourg, United States
Investor stats
- Total investments: 10
- Round size: Seed $1.1M–$7.4M; Pre-Seed $837k–$1.2M; Series A $2.9M–$3.8M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- MultivisionDx — MultivisionDx's computer vision technology integrates the tumor's unique biological and geographical properties, as well as its milieu, to generate patient-specific tumor profiles.
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
- Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.
Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1204
- Round size: Seed $196k–$5.8M; Pre-Seed $104k–$1.1M; Series A $4.6M–$29M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Sapyen — We take the fear out of infertility for men. Test for it at home, without stepping out to the hospital and get personalised health recommendations to improve sperm health and increase your chances of conceiving.
- Superflex — Elevate your workflow with Superflex, the ultimate Figma-to-code solution. Our AI instantly converts Figma and Image designs into pixel-perfect, production-ready code that meets your standards and boosts team efficiency.
- One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 145
- Lead/follow: no public data
Portfolio highlights
- IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
- NovoLINC — NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.
- TRIMTECH Therapeutics — TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $2.4M–$8.7M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Series A, Series C
- Geography: Finland, The Netherlands
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Stefan Lindberg is co-owner of YSUB.
Show more...Investment focus
- Industry: Wellness, Nutrition, Fruit
- Stage:Seed, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $296k–$430k; Pre-Seed $173k–$549k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- YSUB — YSUB produces a beverage containing hemp - lemonade with a hint of hemp seeds, soothing botanicals, and some vitamins. It also has CBD beverage, but cannot sell due to regulations in Finland and other Nordic countries and is trying to create a campaign to create awareness.
- Vegemi — Vegemi is a free smartphone app that promotes eating fruits and vegetables through gaming. The software was designed with the entire family in mind, but especially to demonstrate youngsters the health advantages of fruits and vegetables in a way that motivates and inspires them.
- StepOut.pro — A digital platform for fitness & wellness freelancers to streamline their business activities
Athensmed Oy
Show more...Investment focus
- Industry: Health Care, Medical, mHealth
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $1.1M–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Elias Aalto is Wolt's Advisor and a Co-Founder before that.
Show more...Investment focus
- Industry: Internet, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 10
- Round size: Seed $430k–$10M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cluby — Cluby is a technology platform that provides restaurants with the best tools for managing and communicating with loyal consumers.
- ArcticStartup — ArcticStartup is the leading startup news publication covering the Nordics and Baltics delivering the latest insights on the hottest startups in the region
- Flowstep — Flowstep is a copilot that helps you create better designs, 10x faster. Just type and get user flows, high-fidelity UI, JTBD and more.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: Germany, France, The Netherlands
Investor stats
- Total investments: 247
- Lead/follow: no public data
Portfolio highlights
- Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
- Greenlight Biosciences — Next Generation Crop Protection
- Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned portfolio company.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Therapeutics
- Stage:Seed, Corporate Round, Series A
- Geography: Germany, China, Japan
Investor stats
- Total investments: 10
- Round size: Series A $4.4M–$8.5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- CSMH — Compound Semiconductor (Xiamen) Technology Co., Ltd. is an advanced semiconductor manufacturing technology based joint venture company invested from the Korea, China and Singapore, registered in the city of Xiamen, China. We have equipped with advanced semiconductor manufacturing tools including MPCVD, MOCVD, LPCVD, HVPE and high temperature PVDto produce high quality Diamond wafer and AlN template on various substrate including Si, sapphire, and polished diamond. Our mission is to be the most advanced compound semiconductor company in the global market, contributing to the related technology development. We have strong R&D team and actively collaborate with best research group around the world. Currently, we are providing the thermal grade polycrystalline diamond, which can be used as an effective heat sink aims to solve the heat issue in temperature sensitive device, such as power devices, lasers and avalanche photodiodes etc. We also provides wafer scale polished diamond with sub-nanometer RMS surface roughness, which might be suitable for the integration of GaN, GaO and AlN epilayers and devices on Diamond via direct bonding or heteoepitaxy.
- Holosolis — Holosolis contributes to the EU’s goal of local PV module production and curbing global warming. We will build the largest photovoltaic panel factory in Europe.
- Tsubame BHB — Tsubame BHB is a Sales company
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: Belgium, Germany, The Netherlands
Investor stats
- Total investments: 55
- Lead/follow: no public data
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Mika Ihamuotila - Board of Directors @ Rovio Entertainment Corporation
Show more...Investment focus
- Industry: Sustainability, FinTech, Internet
- Stage:Seed, Post-IPO Equity
- Geography: Finland
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Sulapac — Reduce your CO2 emissions and eliminate microplastic pollution without compromising operational efficiency or customer experience.
- NoHo Partners — NoHo Partners Plc is a Finnish restaurant group behind approximately 250 restaurants, bars, pubs, nightclubs and entertainment centres. The name derives from the words ‘Nordic Hospitality Partners’, which communicate the key goals, opportunities and strengths of the Group.
We fund futurebreakthroughs
Show more...Investment focus
- Industry: Apps, Water, Energy
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 267
- Lead/follow: no public data
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Numab — Numab Therapeutics AG
- Windward Bio — Windward Bio is a clinical-stage drug development company focused on improving outcomes for individuals with advanced immunological diseases, particularly severe respiratory conditions. The company is advancing a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP) into phase 2 development while creating innovative bispecific programsfor various immunological disorders. Led by a team of biopharmaceutical executives, Windward Bio aims to address significant unmet medical needs in this field.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Industry: Genetics, Hospital, Automotive
- Geography: Finland
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Healthcare business development, management, and investing. Very good knowledge on healthcare services and public health. Kustaa Piha is interested in new business and investment opportunities and better ways of producing excellent healthcare services.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Medical Device
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $549k–$1.3M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Sooma — Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.
- Klinik — Klinik® is an innovative health website designed from the very beginning to meet the needs of users. They offer advanced tools for consumers to identify their conditions and to treat them properly, and if needed, they connect them with matching health professionals. It’s a unique platform for health experts to show their true expertise toconsumers. Main characteristics of their offering are:1) Easy access to qualified and reliable health and medical information2) Helping people to identify their conditions3) Providing people valid evidence-based info on self care4) Integrating professional healthcare providers with users requesting additional medical.
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.
Show more...Investment focus
- Industry: Software, Analytics, Semiconductor
- Stage:Series A, Series B, Seed
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 45
- Round size: Seed $1.1M–$3.3M; Series A $3.9M–$8.8M; Series B $2.4M–$16M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $60M in 2010
Portfolio highlights
- Neo4j — Connect data as it's stored with Neo4j. Perform powerful, complex queries at scale and speed with our graph data platform.
- Blackwood Seven — Blackwood Seven is a media analytics platform which strives to increase the effect of company’s media spend using our predictive analytics framework built on machine learning and artificial intelligence. Using real-time modelling and advanced KPI prediction we are able to increase a company’s media ROI by up to 15-25%.
- Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 118
- Lead/follow: no public data
Portfolio highlights
- wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
- Medisolar — Medisol is a food technology firm that also provides personalized food care solutions.
- C2N Diagnostics — C2N Diagnostics, LLC is a privately held protein diagnostic and therapeutic discovery company targeting progressive neurodegeneration. They formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, and LifeTech Research, a Maryland-based technology research andcommercialization firm (www.lifetechresearch.com). They reside at the Center for Emerging Technologies in St. Louis.
Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.
Show more...Investment focus
- Industry: Software, Information Technology, Pet
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
- Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
- Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
Asko Schrey
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Zefort — Zefort is a powerful contract management software. Sign, store, share contracts and easily with your team. Set reminders and use a powerful search.
- ContractZen Governance Suite — ContractZen corporate governance software is ideal for contract management, board meeting management, entity management, e-signature & virtual data room (VDR).
- ReceiptHero — Say goodbye to paper receipts. Cut operational costs, reduce waste and deliver a better in-store experience for customers.
Kristian Ranta is a Co-Founder & Chief Executive Officer at Meru Health.
Show more...Investment focus
- Industry: Health Care, Apps, Internet
- Stage:Seed, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 5
- Round size: Seed $137k–$3.5M; Pre-Seed $380k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AIATELLA — Automating medical image analysis
- Solu — Discover the next generation toolkit for analyzing, storing and sharing bacterial genomes.
- Junction — Vital API allows developers to access health data from wearable devices and at-home test kits. The company was founded in 2021 by Maitham Dib and is headquartered in San Francisco, California, United States.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 26
- Round size: Series A $1.3M–$73M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 83
- Round size: Seed $2M–$5.2M; Pre-Seed $573k–$2.4M; Series A $5M–$22M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- Sober Sidekick — Gamified peer to peer support
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 126
- Round size: Series A $5.7M–$55M; Series B $12M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Health Care Investor funding in Finland at a glance
Stats across 316 deals from 326 investors.
Access all 326 investors in Finland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 326 investors investing in Finland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!